Ophthalmology device startup pulls in $8M; Analysts: GI endoscopy market will reach $2.5B by 2016;

 @FierceMedDev: Siemens buys an ultrasound imaging startup - Penrith Corp. More | Follow @FierceMedDev

 @MarkHFierce: ForSight Vision 5., a ophthalmology device startup, raised $8 million. Via MedCity NewsMore | Follow @MarkHFierce

 @DamianFierce: Another recall from Covidien, this time over its Duet tissue-reinforcement device, tied to three deaths. More | Follow @DamianFierce

> BSD Medical ($BSDM) gained marketing approval in Russia to market its hypothermia treatment devices. Release

> More than 123 million medical device products were recalled in the 2012 second quarter, according to the quarterly ExpertRecall index. Item

> The U.S. gastrointestinal endoscopy market should reach $2.5 billion by 2016, driven by an aging population and greater colorectal cancer screening, Millennium Research Group concludes. Release

> Toshiba America Medical systems secured FDA clearance for its new Vantage Titan 1.5T MR systems. Release

> NanoLogix will start selling new tuberculosis diagnostic tests under FDA 510(k)-exempt status. Release

Biotech News

 @FierceBiotech: Boehringer sets Sept. launch date for pharma's first social game on Facebook. Article | Follow @FierceBiotech

 @JohnCFierce: SEC charges biotech exec with insider trading - first Bristol-Myers Squibb, now Array. Another one of these and I'm calling it a trend. More | Follow @JohnCFierce

 @RyanMFierce: Merck's Varivax slashes U.S. chickenpox cases. More | Follow @RyanMFierce

> Analysts: Roche's armed antibody will help drive breast cancer drug sales. Story

> Gilead writes off $11M gamble after PAH drug flunks PhII. News

> Analysts show why orphan drug development is going gangbusters. Report

Pharma News

 @FiercePharma: Check out the soon-to-be-launched Facebook game from Boehringer, if you haven't already. More | Follow @FiercePharma

> Indian court puts off Novartis patent hearing to Sept. 11. Article

> Ex-rep claims Abbott pushed TriCor off-label. News

> Cipla, Aspen eye joint excursion in Australia. More

Biomarkers News

> Gene signature picks out radiation-sensitive cancers. Story

> Blood biomarkers could pinpoint common kidney disease. More

> It's all relative: Protein marks lower dementia risk in siblings. Item

> Biomarker signatures tag liver transplant failure. Article

Drug Delivery News

> Tobacco money funds NanoJacket cancer drug delivery. News

> Ocular Therapeutix eyes punctal delivery in Phase II. Story

> Protein capsules fight a toothy battle. Article

> DNA origami delivers doxorubicin, downs resistance. More

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.